can semaglutide cause liver problems Diabetes and obesity drug shows promise for fatty disease What are the risks of

Historically, patients paying out-of-pocket for GLP-1 (glucagon-like peptide-1) medications faced costs exceeding $1,000 a month

It usually follows a pattern like 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg per week

What was once a stepwise sequence: metformin, sulfonylurea, insulin: has become a personalised choice, with classes (GLP-1 receptor agonists, SGLT2 inhibitors, dual GIP/GLP-1 agonists) chosen as much for cardiovascular and renal protection as for blood-glucose control

With rapid weight loss, that support structure can change faster than the skin can respond

Melanocytic naevi of the oral mucosa: a clinicopathologic study of 130 cases from northern California